Covered recipient · General Payments record
AMER RASSAM
General Payments · PY2018–2024
$6,049.20
- Reported across 201 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $1,558.56 | 56 |
| Travel and Lodging | $1,080.85 | 2 |
| Education | $106.06 | 2 |
| Gift | $33.10 | 1 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| US Oncology Corporate, Inc. | $1,515.95 | 4 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $197.00 | 9 |
| PFIZER INC. | $127.98 | 6 |
| Astellas Pharma US Inc | $124.42 | 2 |
| GENZYME CORPORATION | $99.14 | 4 |
| Celgene Corporation | $98.24 | 5 |
| EISAI INC. | $58.78 | 3 |
| Genentech USA, Inc. | $47.64 | 2 |
| Acerta Pharma LLC | $46.17 | 2 |
| Novocure Inc. | $45.75 | 3 |
| Merck Sharp & Dohme Corporation | $45.39 | 2 |
| Lilly USA, LLC | $43.38 | 2 |
| GlaxoSmithKline, LLC. | $41.27 | 2 |
| Exelixis Inc. | $39.18 | 2 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $31.87 | 1 |
| Coherus Biosciences Inc. | $29.26 | 2 |
| Daiichi Sankyo Inc. | $28.37 | 1 |
| ARRAY BIOPHARMA INC | $24.63 | 1 |
| Incyte Corporation | $24.51 | 1 |
| SERVIER PHARMACEUTICALS LLC | $20.67 | 1 |
| Janssen Biotech, Inc. | $19.88 | 1 |
| Tempus AI, Inc | $18.05 | 1 |
| E.R. Squibb & Sons, L.L.C. | $16.67 | 1 |
| Teva Pharmaceuticals USA, Inc. | $14.47 | 1 |
| Pharmacosmos Therapeutics Inc. | $13.79 | 1 |
| Rigel Pharmaceuticals, Inc. | $6.11 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (61)
Sorted by paying entity, then date · as published by CMS
Program year 2024 201820192020202120222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.